| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | Chief Operating Officer +2 more
2 companies
Kelderman Kim serves as a Chief Executive Officer at TECH and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 8 sells.
Historically, Kelderman Kim's trades have earned a middling insider score of 67/100 across 5 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +24.6%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | TECH Bio-Techne Corp | Chief Executive Officer | Sale+OE | 13,392 | $77.29 | $1,035,013.42 | -25.6% | -34.3% | -10.8% | |
| Nov 19, 2021 | TECH Bio-Techne Corp | President Diagnostics &Genom | Sale+OE | 500 | $505.38 | $252,689.00 | - | -20.5% | -34.2% | |
| Sep 22, 2021 | TECH Bio-Techne Corp | President Diagnostics &Genom | Sell | 822 | $529.04 | $434,870.88 | -100% | -10.0% | -45.4% | |
| Jun 9, 2021 | TECH Bio-Techne Corp | President Diagnostics &Genom | Sell | 811 | $433.00 | $351,163.00 | -100% | +19.9% | -16.9% | |
| May 25, 2021 | TECH Bio-Techne Corp | President Diagnostics &Genom | Sell | 845 | $424.00 | $358,280.00 | -51.0% | +14.3% | -15.8% | |
| Feb 5, 2021 | TECH Bio-Techne Corp | President Diagnostics &Genom | Sell | 823 | $388.45 | $319,694.35 | -49.3% | - | - |